![Kristen Slaoui](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kristen Slaoui
Director/Board Member at
Kinaset Therapeutics, Inc.
Net worth: - $ as of 30/06/2026
Profile
Kristen Belmonte Slaoui is currently Director at Kinaset Therapeutics, Inc. and Chief Corporate Development Officer at Galderma SA (Switzerland).
Former roles include Director at Villaris Therapeutics, Inc. from 2019 to 2022, Independent Director at Achieve Life Sciences, Inc. from 2025 to 2026, Vice President at Tesaro, Inc., Vice President & Head-Business Development at GSK Plc from 2015 to 2020, and Vice President-Business Development & Licensing at Stiefel Laboratories, Inc. from 2012 to 2020.
Education includes undergraduate studies at Gettysburg College and a doctorate from Johns Hopkins Bloomberg School of Public Health.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 20/04/2026 | 0 ( -.--% ) | - $ | 30/06/2026 |
Kristen Slaoui active positions
| Companies | Position | Start |
|---|---|---|
Kinaset Therapeutics, Inc.
 Kinaset Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops inhaled therapeutics for respiratory diseases | Director/Board Member | - |
Galderma SA (Switzerland)
 Galderma SA (Switzerland) Pharmaceuticals: MajorHealth Technology Manufactures and distributes dermatology products | Corporate Officer/Principal | - |
Former positions of Kristen Slaoui
| Companies | Position | End |
|---|---|---|
| ACHIEVE LIFE SCIENCES, INC. | Director/Board Member | 02/07/2026 |
Villaris Therapeutics, Inc.
 Villaris Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as an asset-centric biopharmaceutical company | Director/Board Member | 01/11/2022 |
Stiefel Laboratories, Inc.
 Stiefel Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | 02/08/2020 |
| GSK PLC | Corporate Officer/Principal | 01/08/2020 |
| TESARO INC | Corporate Officer/Principal | - |
Training of Kristen Slaoui
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
60
1st degree connections
9
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 9 |
|---|---|
Tesaro, Inc.
 Tesaro, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops drugs for cancer patients | Health Technology |
GSK Plc
 GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
Gettysburg College
 Gettysburg College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Stiefel Laboratories, Inc.
Stiefel Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Johns Hopkins Bloomberg School of Public Health
 Johns Hopkins Bloomberg School of Public Health Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Galderma SA (Switzerland)
Galderma SA (Switzerland) Pharmaceuticals: MajorHealth Technology Manufactures and distributes dermatology products | Health Technology |
Achieve Life Sciences, Inc.
 Achieve Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes cytisinicline for smoking cessation and nicotine addiction | Health Technology |
Kinaset Therapeutics, Inc.
Kinaset Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops inhaled therapeutics for respiratory diseases | Health Technology |
Villaris Therapeutics, Inc.
Villaris Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as an asset-centric biopharmaceutical company | Health Technology |
- Stock Market
- Insiders
- Kristen Slaoui
Choose MarketScreener 
